Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-06T23:22:32.806Z Has data issue: false hasContentIssue false

The stability of the serotypes of Bordetella pertussis with particular reference to serotype 1,2,3,4

Published online by Cambridge University Press:  15 May 2009

Caroline J. Bronne–Shanbury
Affiliation:
The Lister Institute of Preventive Medicine, Elstree, Hertfordshire
Jean M. Dolby
Affiliation:
The Lister Institute of Preventive Medicine, Elstree, Hertfordshire
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Strains of Bordetella pertussis in which all the organisms contain agglutinogens 1 and 3 or 1, 2 and 4 are easy to identify as serotypes 1,0,3,0 and 1,2,0,4 respectively; and similarly, stable strains of serotype 1,0,3,4 are occasionally found. During repeated subcultures, passage in vivo, and lyophilization and preservation for many years, these serotypes do not change. Mixing 1,0,3,0 and 1,2,0,4 serotypes and culturing them together in vivo and in vitro produces cultures from which organisms of the same two serotypes can be isolated.

In contrast, strains which type as 1,2,3,4 are often a heterogeneous group. We have attempted to classify these as 'stable', 'variable' and 'mixed' cultures. Some strains comprise organisms all of which contain the four agglutinogens and are as easy to type as the strains described above. These we have called 'stable' 1,2,3,4 strains. Other 1,2,3,4 strains are made up of colonies possessing all four agglutinogens, as shown by agglutinin production, but in amounts varying from day to day so that direct typing is inconsistent. These we have called 'variable' 1,2,3,4 strains. The last category, 'mixed', is made up of organisms most of which give rise to stable 1,2,3,4 cultures; a few of the component organisms, however, have one or two of the four agglutinogens missing. The importance of the 'variable' cultures is emphasized for work on apparent change of serotype, e.g. during infection.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1976

References

REFERENCES

Andersen, E. K. (1953). Serological studies on Haemophilus pertussis, Haemophilus para-pertussis and Haemophilus bronchisepticus. Acta pathologica et microbiologica scandinavica 33, 202–24.Google Scholar
Bronne-Shanbury, C. J. (1976). The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis. Journal of Hygiene 76, 257–64.Google Scholar
Bronne-Shanbury, C. J., Miller, D. & Standfast, A. F. B. (1976). The serotypes of Bordetella pertussis in Britain between 1941 and 1968 and a comparison with serotyping in other countries over this period. Journal of Hygiene 76, 265–75.CrossRefGoogle Scholar
Cameron, J. (1967). Variation in Bordetella pertussis. Journal of Pathology and Bacteriology 94, 367–74.CrossRefGoogle ScholarPubMed
Cohen, S. M. & Wheeler, M. W. (1946). Pertussis vaccine prepared from phase I cultures grown in fluid medium. American Journal of Public Health 36, 371–3.Google Scholar
Dolby, J. M. & Bronne-Shanbury, C. J. (1975). The use of spheroplast-derived strains to differentiate between Bordetella pertussis heat-labile agglutinogens and protective antigen in mice. Journal of Biological Standardisation 3, 89100.CrossRefGoogle Scholar
Dolby, J. M. & Stephens, S. (1973). Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. Journal of Hygiene 71, 193207.CrossRefGoogle ScholarPubMed
Eldering, G., Hornbeck, I. C. & Baker, J. (1957). A serological study of Bordetella pertussis and related species. Journal of Bacteriology 74, 133–6.Google Scholar
Holt, L. B., Spasojevic, V., Dolby, J. M. & Standfast, A. F. B. (1961). Immunity in mice to an intracerebral challenge of Bordetella pertussis. Journal of Hygiene 59, 373–8.CrossRefGoogle Scholar
Public Health Laboratory Survey (1973). Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. Final report. British Medical Journal i, 259–62.Google Scholar
Preston, N. W. (1963). Type-specific immunity against whooping-cough. British Medical Journal ii, 724–6.CrossRefGoogle Scholar
Stanbridge, T. N. & Preston, N. W. (1974 a). Experimental pertussis infection in the marmoset: type specificity and immunity. Journal of Hygiene 72, 213–28.CrossRefGoogle Scholar
Stanbridge, T. N. & Preston, N. W. (1974 b). Variation of serotype in strains of Bordetella pertussis. Journal of Hygiene 73, 305–10.CrossRefGoogle ScholarPubMed
Zakharova, M. S., Gorbunova, Z. V., Kuznetsov, E. A. & Denisova, T. P. (1970). Symposia series in immunobiological standardisation no. 13, International Symposium on Pertussis, p. 34. Basel, Munchen, New York: Karger.Google Scholar